Cocrystal Pharma (NASDAQ:COCP) reported quarterly losses of $(0.70) per share. This is a 45.83 percent decrease over losses of $(0.48) per share from the same period last year.
Synopsys And Samsung Foundry Deepen Collaboration To Accelerate Multi-Die System Design For Advanced Samsung Processes
Synopsys IP and Certified EDA Design Reference Flow Speed Heterogeneous Integration on SF5/4/3 Nodes
Certified multi-die system design reference flow and secure die-to-die IP speed design and silicon success for
